Micro Developing Active

HIMS expands access to Novo Nordisk's GLP-1 medications

Puntuación
0,4
Velocidad
▲ 0,0
Artículos
5
Fuentes
2

Resumen

An article belongs to this narrative if it discusses Hims & Hers' expansion of access to Novo Nordisk's GLP-1 medications.

Fuentes

Hims & Hers (HIMS) Taps Into $200-Billion Weight Loss Market, … Yahoo Finance
Novo Partnership Fuels Long-Term Optimism for Hims & Hers Health, … Yahoo Finance
Mars CEO gets board role at GLP-1 supplier Novo Nordisk Yahoo Finance
Hims & Hers shifts business model after Novo deal Yahoo Finance

Cronología

Última actualización Mar 27, 2026